New anticoagulants: how to deal with treatment failure and bleeding complications. - Wikidata - wikimedia - TriplyDB

New anticoagulants: how to deal with treatment failure and bleeding complications.

New anticoagulants: how to deal with treatment failure and bleeding complications.

http://www.wikidata.org/entity/Q37900670

about

Reversal of oral anticoagulation Pregnancy-specific glycoproteins bind integrin αIIbβ3 and inhibit the platelet-fibrinogen interaction Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation.Facile chemoenzymatic synthesis of biotinylated heparosan hexasaccharide.Rivaroxaban in the treatment of venous thromboembolism and the prevention of recurrences: a practical approach.Anticoagulant therapy and its impact on dental patients: a review.Novel anticoagulants - an update on the latest developments and management for clinicians treating patients on these drugs.What neurosurgeons need to know about dabigatran etexilate (pradax(®)/pradaxa(®)/prazaxa(®)).Dual Anticoagulation in Recurrent Thromboembolic Events with Failure of Monotherapy: A Novel Approach.Should all septic patients be given systemic anticoagulation? No.

P2860

Q26827835-856D8826-C923-49F6-95A6-78A8EF25A823 Q28595015-5DF6FD3D-B7DD-4F77-958A-182DB94CB3E4 Q35746798-20D7F524-3225-45AA-B8DF-DBEA830462A9 Q35754841-2A6EA8E6-2B53-42C9-A4D2-9BCE3FBB3488 Q38287849-B1CD8180-9EC3-4139-A1C5-EA113272A84F Q38515689-08D815EA-E696-49F1-8372-1F7EF1B0D33E Q38793747-FDABFE82-7FD4-4D36-BB87-4695D6722FF5 Q39189294-B1A1E902-EFA3-4E9B-A08B-DA05EF785B8A Q41556202-9C590CB8-B6C5-4985-B3C3-33783E479C9E Q44196218-E54FC72E-69CD-48EA-A19A-624798246578

P2860

New anticoagulants: how to deal with treatment failure and bleeding complications.

http://www.wikidata.org/entity/Q37900670

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New anticoagulants: how to deal with treatment failure and bleeding complications.

@en

New anticoagulants: how to deal with treatment failure and bleeding complications.

@nl

type

label

New anticoagulants: how to deal with treatment failure and bleeding complications.

@en

New anticoagulants: how to deal with treatment failure and bleeding complications.

@nl

prefLabel

New anticoagulants: how to deal with treatment failure and bleeding complications.

@en

New anticoagulants: how to deal with treatment failure and bleeding complications.

@nl

P1433

Q37900670-4B773639-CE06-4905-A0D9-BAE9E5ED53D4

P1476

Q37900670-C23E90DF-553B-448B-9B14-9FC6A17A18F4

P2093

Q37900670-A6FFE4C0-EFB4-460A-A7BF-2156044D3379

Q37900670-C1E182B4-A3E2-42BA-AE53-A70BF0E5DD4B

P2860

Q37900670-057290DF-101D-4962-8EB4-77B52E1E3E65

Q37900670-0645DF51-312F-4F48-99D0-5BF320CA3277

Q37900670-08E56729-A775-47C9-BA8A-BF563240B2D9

Q37900670-0B0EB72F-B039-480B-B9D0-597865A09ABE

Q37900670-0D319193-31B7-444B-A43B-8E9B0747CF4C

Q37900670-0F8E187D-05C6-41AE-8A81-63FD4A28C0BA

Q37900670-14197A85-3143-4E75-9A50-B32649D31A55

Q37900670-14934270-C792-4636-9505-0C7A4F83338E

Q37900670-1A07C7E2-D9D9-401F-9002-CF6078F466E5

Q37900670-2186D9B6-098A-4FBF-AC61-21AFF6AF10C7

P304

Q37900670-08360793-BE95-4BFF-AA24-236E3905C393

P31

Q37900670-135A660D-FA69-44A3-A8B9-D0CCCB02FEC1

P356

Q37900670-CC19D836-D98F-43EA-979E-36847F75BB12

P407

Q37900670-EC15BE22-42BC-4BD0-AFB9-44D0840B4E2F

P433

Q37900670-BC89DE9A-03B6-4DCA-8AA3-9211F22CAFAC

P478

Q37900670-058CB1C9-972A-4237-B6AB-37E322A53C1C

P577

Q37900670-F7416D1D-18DF-44E3-B5B7-B6A79063D226

P5875

Q37900670-12BFF6F2-73D1-4ECD-B273-D13DCE8AC99A

P698

Q37900670-B1ADAD6F-58AD-4B5D-B94C-6D18E7083A18

P921

Q37900670-297D22B3-1979-4124-A951-D768C06E53A3

P932

Q37900670-F17C837D-935B-4DDB-96CD-465D1F638EF0

P356

J.1365-2125.2011.04060.X

P1433

British Journal of Clinical Pharmacology

P1476

New anticoagulants: how to deal with treatment failure and bleeding complications.

@en

P2093

Bashir A Lwaleed

http://www.w3.org/2001/XMLSchema#string

Rashid S Kazmi

http://www.w3.org/2001/XMLSchema#string

P2860

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

Warfarin, aspirin, or both after myocardial infarction

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939--an oral, direct Factor Xa inhibitor

Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement

Dabigatran versus warfarin in patients with atrial fibrillation

Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

Oral rivaroxaban for symptomatic venous thromboembolism

A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.

P304

593-603

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.2011.04060.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51488439

http://www.w3.org/2001/XMLSchema#string

P698

21752066

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

3195736

http://www.w3.org/2001/XMLSchema#string